Results from two Phase III multi-country trials (ASPIRE and Ring) studying the 4-week slow-release dapivirine vaginal ring were released at the 2016 Conference on Retroviruses and Opportunistic Infection. This chart details study design and enrollment, gives overall results and breaks results down by age.
ASPIRE and The Ring Study Results — A Snapshot
Px Wire January-March 2016, Vol. 9, No. 1
Px Wire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. In this issue we survey the year ahead and write about what to watch for in 2016. In our centerspread we update our timeline of biomedical HIV prevention research.
Effectiveness and Adherence in Trials of Oral and Topical Tenofovir-Based Prevention
Trials of oral and topical tenofovir-based PrEP show that these strategies reduce risk of HIV inection if they are used correctly and consistently. Higher adherence is directly linked to greater levels of protection.
Anatomy of a Target – Treatment U=U
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at antiretroviral therapy and Treatment U=U.
Anatomy of a Target – PrEP
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at PrEP.
Anatomy of a Target – VMMC
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at VMMC.
Anatomy of a Target – DREAMS
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at the DREAMS program.
The New Context for HIV Prevention: Is the world on target?
In this issue of Px Wire, our centerspread graphic looks at the sum total of the new targets and guidelines and gives our “take” on whether the current context is on target.
A Pipeline of Promise: Global Health Research and Product Development Process
Global Health Technologies presents an infographic overview of the many steps it takes to bring a product to market.
A Pipeline of Promise: Global Health Research and Product Development Process
Global Health Technologies presents an infographic overview of the many steps it takes to bring a product to market.